Country: United States
Language: English
Source: NLM (National Library of Medicine)
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)
Cardinal Health
BENZALKONIUM CHLORIDE
BENZALKONIUM CHLORIDE 0.133 g in 100 g
OTC DRUG
OTC monograph not final
CARDINALHEALTH ANTISEPTIC BZK TOWELETTES- BENZALKONIUM CHLORIDE SWAB CARDINAL HEALTH _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- CARDINALHEALTH ANTISEPTIC BZK TOWELETTES CARDINALHEALTH ANTISEPTIC BZK TOWELETTES ACTIVE INGREDIENT Benzalkonium Chloride, 0.133% PURPOS E Antiseptic US E First antiseptic to help prevent the risk of infection in minor cuts, scrapes and burns. WARNINGS FOR EXTERNAL USE ONLY. FOR PROFESSIONAL AND HOSPITAL USE. DO NOT USE for deep puncture wounds, animal bites, or serious burns. In the eyes on mucous membranes on irritated skin over large areas of the body STOP USE AND ASK A DOCTOR IF irritation, redness, or symptoms develops if the condition persists or gets worse. KEEP OUT OF REACH OF CHILDREN. If swallowed, get medical help or contact a Poison Control Center immediately. OTHER INFORMATION Store at room temperature DIRECTIONS FOR USE Open packet and use a washcloth INACTIVE INGREDIENT purified water CARDINALHEALTH ANTISEPTIC BZK TOWELETTES 100 TOWELETTES (63517-323-02) CARDINALHEALTH ANTISEPTIC BZK TOWELETTES Cardinal Health CARDINALHEALTH ANTISEPTIC BZK TOWELETTES benzalkonium chloride swab PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:6 3517-323 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH BENZALKO NIUM CHLO RIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6 JUD5X6 Y) BENZALKONIUM CHLORIDE 0 .133 g in 10 0 g INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH WATER (UNII: 0 59 QF0 KO0 R) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:6 3517- 323-0 2 10 0 in 1 BOX 0 8 /0 3/20 16 1 1.5 g in 1 PATCH; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DA Read the complete document